Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FERUMOXYTOL
- A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment
- Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
- Predicting Stroke Risk in ICAD With Novel MRI
- Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
- IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
- Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
- Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
- FOLFIRINOX + 9-Ing-41 + Losartan In Adenocarcinoma
- A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
- Placental Lesions in Fetal Growth Restrictions
- Virtual Histology of the Bladder Wall for Bladder Cancer Staging
- Early Antenatal Support for Iron Deficiency Anemia
- Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
- IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
- Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support
- A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
- Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient
- MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
- Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases
- Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer
- Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
- Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors
- In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI
- Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography
- Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI
- Ferumoxytol for Magnetic Resonance Imaging in Patients With Severe Kidney Disease
- Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
- Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer
- Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease
- A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
- MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer
- Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
- Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors
- Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI
- In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
- Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
- A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
- qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
- Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
- Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
- DEtection of Cellular Inflammation With FERumoxytol in the HEART
- Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer
- Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
- DCE MRI in Patients With Pancreatic Cancer
- Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance
- Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer
- High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases
- Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
- Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study
- Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI
- MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
- Aspirin Attenuates Inflammation in Human Cerebral Aneurysms
- Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
- Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
- Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- Imaging of Type 1 Diabetes Progression
- Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
- Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
- Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer
- A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
- Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
- Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
- Iron Indices and Intravenous Ferumoxytol: Time to Steady State
- A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
- A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia
- A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
- A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
- DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors
- Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy
- Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)
- MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
- MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation
- Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
- A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women
- A Crossover Safety Study of Ferumoxytol Versus Placebo
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients
- Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
- Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer
Clinical trials list
click for details